Unlike their mega-cap counterparts, which tend to grind, mid-caps can soar or crash within days, driven by headlines and pure speculation.
We are still pretty early in the new year, but some companies are already delivering outsize returns to their shareholders. Akero Therapeutics (NASDAQ: AKRO) is part of this group. On Jan. 27, the company's...
The S&P 500 Index ($SPX ) (SPY ) Monday closed down -1.46%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.65%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.97%. March E-mini...
/AI%20(artificial%20intelligence)/A%20hand%20holding%20a%20smartphone%20with%20the%20deepseek%20AI%20logo_%20Image%20by%20Poetra_RH%20via%20Shutterstock_.jpg)
The S&P 500 Index ($SPX ) (SPY ) today is down -1.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.68%. March E-mini S&P futures...
The S&P 500 Index ($SPX ) (SPY ) today is down -1.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.66%. March E-mini S&P futures...
The analyst highlighted that major pharmaceutical companies are already pursuing GLP-1-based therapies for MASH, but he believes efruxifermin could complement these treatments.